BMYB34:BVMF
Bristol-Myers Squibb Company BDR
R$317.76
0.00%
(0.00) 1D
Sep 23, 2:31:54 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMYB34...
Mkt. cap
124.91B
Avg. vol.
77.00
Volume
0.00
52-wk high
R$349.41
52-wk low
R$223.16
Shares outstanding
2.04B
No. of employees
32K
Mkt. cap
124.91B
Avg. vol.
77.00
Volume
0.00
52-wk high
R$349.41
52-wk low
R$223.16
Shares outstanding
2.04B
No. of employees
32K
News stories
From web sources and news partners
FinanzNachrichten.de
·
1 hour ago
Bristol-Myers Squibb Company: Leveraging Brazil's Health Networks for Early Lung Cancer Detection
AD HOC NEWS
·
3 hours ago
Bristol Myers Squibb stock falls 1.77 percent after Q2 gains fade
AD HOC NEWS
·
5 hours ago
Bristol Myers Squibb stock slips 1.8 percent before the bell
AD HOC NEWS
·
18 hours ago
Bristol-Myers Squibb stock slips 1.73 percent on September 23
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Company BDR
CEOChris Boerner
Employees32.5K
Founded1887
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitebms.com